NasdaqGM - Nasdaq Real Time Price
USD
Turn Therapeutics Inc. (TTRX)
10.43
-0.29
(-2.71%)
At close: October 30 at 4:00:00 PM EDT
10.65
+0.22
(+2.11%)
After hours: October 30 at 5:33:08 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mohammed Zubair
|
Controller | -- | -- | -- |
|
Dr. Stephen M. Hahn FASTRO, M.D.
|
Executive Clinical & Regulatory Lead | -- | -- | 1960 |
Turn Therapeutics Inc.
250 N Westlake Blvd
STE 210
Westlake Village, CA 91362
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2
Description
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Corporate Governance
Turn Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2026 at 9:00 PM UTC
Turn Therapeutics Inc. Earnings Date
